A Phase 2, Double-Blind, Randomized, Placebo-Controlled, 4-Arm Study to Investigate Symptoms, Function, Health-Related Quality of Life and Safety With Repeated Subcutaneous Administration of Ponsegromab Versus Placebo In Adult Participants With Heart Failure (NCT05492500)
GARDEN
This trial is Currently recruiting
Registration number NCT05492500
Program & service
This trial is being run with the Heart & Lung service, and as part of the Cardiology program.
Trial phase
Phase 2
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principle investigator
Professor David Kaye
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.